key: cord-0868500-p54c4dug authors: Sharun, Khan; Dhama, Kuldeep title: COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic date: 2021-04-23 journal: Arch Med Res DOI: 10.1016/j.arcmed.2021.04.006 sha: 5c75da1d7c68c0b37e7e13c8de49b84884ec0707 doc_id: 868500 cord_uid: p54c4dug The wealthy countries have already secured 60% of the total coronavirus disease (COVID-19) vaccine supplies for their citizens. Some of these countries have pre-ordered vaccine doses sufficient enough to vaccinate their population multiple times. India has recently initiated a diplomatic mission named "Vaccine Maitri" to provide COVID-19 vaccine doses to needy low-income countries. The ability of the country to manufacture cost-effective vaccines along with the ability to export large vaccine consignments worldwide will help to meet the global COVID-19 vaccine requirements. Furthermore, global vaccination coverage can only be achieved by ensuring equitable access to COVID-19 vaccines. The mission to vaccinate every citizen is going in full swing to tackle the ongoing pandemic. Following the widespread impact of the COVID-19 pandemic globally, wealthy countries accounting for 16% of the world population pre-ordered billions of vaccine doses. These wealthy countries have already secured 60% of the total vaccine supplies for their citizens (1,2). Among the "vaccine nationalists," Canada tops the list, pre-ordering vaccine doses sufficient to vaccinate nine times its population, while the United Kingdom has enough doses to vaccinate six times its population. Other countries such as the United States, Australia, Chile, and members of the European Union, pre- India contributes 60% of the global vaccine supply and acts as the major vaccine manufacturing hub. The cost-effective vaccine development and manufacturing capacity, along with the ability to export large vaccine consignments worldwide, will enable the country to meet the global COVID-19 vaccine requirements. Furthermore, the ability to manufacture low-cost COVID-19 vaccines will be beneficial to the low-income countries that cannot pay for expensive vaccines. This will ensure equitable access to COVID-19 vaccines and can help to achieve global vaccination coverage (4, 5) . When most of the countries are busy procuring COVID-19 vaccine doses for vaccinating their population, India recently started a diplomatic mission named "Vaccine Maitri" (Maitri means friendship in Hindi), an initiative to provide COVID-19 vaccines to the needy low-income countries (4, 6) . The country has supplied a total of 105.15 lakh doses of COVID-19 vaccine to 44 countries as a grant (Table 1) agreement, especially to temporarily defer the IPR of SARS-CoV-2 vaccines, will ensure equitable access to vaccines. Although the WHO Director-General supported the proposal, the United States, the United Kingdom, Canada, Norway, and the European Union opposed such a move (2, 4, 8) . The ongoing COVID-19 pandemic continues to affect the lives of millions across the globe. Global health diplomacy (GHD) can constitute a bridge of international cooperation, resource allocation, and mutual strategic trust to counter public health crisis. Efforts have to be taken to strengthen the existing health management systems and infrastructure via focusing on universal health coverage, strengthening multilateral and multidimensional collaboration to mitigate inequality. The diagnostic tools, therapeutics, and vaccines should be made available to all individuals irrespective of nationality and race for achieving sustainable and equitable development. Such a move will serve as a catalyst for future global health initiatives. In this way, the countries that are unable to procure vaccines could save their vulnerable population from the pandemic, thereby contributing to the global fight against COVID-19 (9). Development and large-scale manufacturing of immunogenic, safe, and cost-effective COVID-19 vaccines with high global cooperation, leadership, and health diplomacy along with implementing impactful public policies that can ensure equitable access to all the countries will ensure global vaccine security (7) (8) (9) (10) . This will certainly help meet the global vaccine requirement and counter the ongoing pandemic and provide avenues for achieving sustainable health-promoting goals for fighting future pandemics. India's Vaccine Diplomacy Access to COVID-19 vaccines: looking beyond COVAX What share of the population has received at least one dose of the COVID-19 vaccine? India's vaccine diplomacy aids global access to COVID-19 jabs India's cost-effective COVID-19 vaccine development initiatives Ministry of External Affairs -Government of India. Vaccine Supply 2021 Vaccine diplomacy: Exploring the benefits of international collaboration Global health diplomacy at the intersection of trade and health in the COVID-19 era Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members The authors received no funding in relation to this article. All authors declare that there exist no commercial or financial relationships that could, in any way, lead to a potential conflict of interest.